-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-section-2-tech-specs.pdf
January 01, 2011 - CHIPRA 133: Section 2 Technical Specifications
Section II: Detailed Measure Specifications
Provide sufficient detail to describe how a measure would be calculated from the
recommended data sour…
-
www.ahrq.gov/hai/pfp/haccost2017-appendix.html
November 01, 2017 - Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions
Appendixes
Previous Page
Table of Contents
Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions
Discussion
Resu…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-figure-1-tables-1-5.pdf
January 01, 2011 - pulmonary
communication skills, and key
educational messages
complications such as
tuberculosis, sickle … cell
disease, cystic fibrosis)
(N=870)
2 Low-income children in the treatment group tended to have
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/reports/issue-briefs/dxsafety-reimagining-healthcare-teams.pdf
July 07, 2023 - Perceived discrimination, patient trust, and
adherence to medical recommendations among persons with sickle … cell disease.
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-medication-safety.pdf
April 30, 2025 - Purpose: Evaluate automated detection methods for adverse drug events (ADEs) in
pediatric patients with sickle … cell anemia, cystic fibrosis, and cancer in the ambulatory
setting. … Key Findings/Impact: Researchers found a high rate of ADEs in pediatric patients
with sickle cell disease
-
www.ahrq.gov/sites/default/files/2024-10/gorelick-report.pdf
January 01, 2024 - vomiting seizures/seizure disorder
excludes: febrile seizures
developmental delay
cystic fibrosis sickle … cell disease failure to thrive
diabetes mellitus spinal cord injuries
hemophilia or other bleeding
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-131-fullreport.pdf
April 05, 2017 - Outpatient follow-up and rehospitalizations for sickle
cell disease patients.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - Identifying sickle cell disease cases using
administrative claims.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/opioids-1.pdf
March 01, 2020 - ED,
with 1 visit
primarily driven
by opioid-
seeking
behavior; adults
age 18–67,
cancer and
sickle … cell
disease
excluded
Control group
(crossover)
One ED in
Indianapolis,
IN, serving
102,000
-
www.ahrq.gov/sites/default/files/publications2/files/hac-cost-report2017.pdf
November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions
FINAL REPORT
Estimating the Additional Hospital Inpatient
Cost and Mortality Associated With
Selected Hospital-Acquired Conditions
PREPARED FOR:
Agency for Healthcare Resear…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hac-cost-report2017.pdf
November 01, 2017 - Draft Final Report Estimating the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital Acquired Conditions
FINAL REPORT
Estimating the Additional Hospital Inpatient
Cost and Mortality Associated With
Selected Hospital-Acquired Conditions
PREPARED FOR:
Agency for Healthcare Resear…